Newsroom

Clinical ink, a global life science technology company, has partnered with a leading biopharmaceutical organization focused on Parkinson’s Disease research to deploy remote technology that captures study participants’ symptoms at home and clinical sites in the United States and Europe.

Attributes 241% revenue growth to therapeutic expertise and technological innovation Horsham, Pennsylvania; November 16, 2022 — Clinical ink, a global life science …

Study participant completes a visual short-term memory (VSTM) cognitive task

A research study within the US Military Health System deploys Clinical ink’s platform among those with and without COVID-19 to understand long …

Will deliver competitive commercial impact via differentiated technological, scientific expertise and operational efficiencies September 19, 2022 — Today Clinical ink, a global …

Man sitting on a parkbench looking at his smart phone

Product enhancements ensure faster, more reliable, and higher quality data collection Horsham, Pa.; September 14 , 2022 — Today Clinical ink, a …

Patient looking at smartwatch

Chief Innovation Officer to Speak on Importance of Applying User Experience Design Practices at DPHARM tech showcase and Mobile Technology in Clinical …

Corporate LiveWire Innovation Award

Corporate LiveWire’s Innovation & Excellence Awards Honors Clinical ink and its Innovative Approach to Industry Challenges Horsham, Pa.; August 15, 2022 — …

Woman looking at wearable medical smart watch device on her arm.

Oxford NeuroMetrology Group Successfully Deploys Clinical ink Mobile Platform to Monitor Parkinson’s Patients at Home Horsham, Pa.; August 11, 2022 — Clinical …

Scroll to Top